Minimum Order Quantity | 100 Box |
Packaging Size | 10x10 AA |
Brand | Atorcube-20 |
Manufacturer | veecube |
Composition | Atorvastatin Tablet 20mg |
Prescription/Non prescription | Prescription |
Promotional Material | Visiting Cards, Diaries, Writing Pads, Working Bag |
Minimum Order Quantity | 100 Box |
Strength | 10 mg |
Packaging Size | 10x10 AA |
Brand | ROSUCUBE-10 |
Manufacturer | RAYLARK |
Composition | Rosuvastatin Calcium eq to Rosuvastatin 10 mg |
Prescription/Non prescription | Prescription |
Medicine Type | Allopathic |
Form | Tablet |
Do you offer Generic or Brand | Only Brand |
Promotional Material | Diaries, Visiting Cards, Writing Pads, Working Bag |
Country of Origin | Made in India |
BRAND NAME-ROSUCUBE-10
COMPOSTON-Rosuvastatin Calcium eq to Rosuvastatin 10 mg
PACKING- 10X10 AA
MRP 150 PER STRIP
Minimum Order Quantity | 50 Box |
Dose/Strength | 20 mg |
Form | Tablets |
Packaging Type | Alu-Alu |
Packaging Size | 10*10 Tablets |
Brand | TENLICUBE 20 |
Composition | TENELIGLIPTIN 20MG TABLET |
Usage | diabetes mellitus |
Shell Life | 24 MONTHS |
Also gives | PCD Pharma Franchise |
BRAND NAME- TENLICUBE 20MG TABLETS
COMPOSITION- TENELIGLIPTIN 20MG TABLET
PACKING- 10*10
MRP- 124/- PER STRIP
Minimum Order Quantity | 500 Box |
Pack size | 10X10 Blister |
Brand | Pride PM2 |
Manufacturer | VEECUBE |
Composition | Brand Name- Pride PM2 Composition- Glimepride 2mg+metformin 500mg (SR) + pioglitazone 15mg( Bilaye |
Medicine Type | Allopathic |
Promotional Material | Diaries, Working Bag, Writing Pads, Visiting Cards |
Form | Tablet |
Brand Name- Pride PM2
Composition- Glimepride 2mg+metformin 500mg (SR) + pioglitazone 15mg( Bilayered tablet)
MRP Rs 110/- Per Strip
Packing 10x10 Blister
Our company is the major in offering Pride PM2to the clients. Its combination of the Glimepride 2mg+metformin 500mg (SR) + pioglitazone 15mg( Bilayered tablet)
Pioglitazone and Glimepiride Tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus who are already treated with a thiazolidinedione and sulfonylurea or who have inadequate glycemic control on a thiazolidinedione alone or a sulfonylurea alone